Updated Jul 16, 2026 · Last SEC filing 2026-07-07
Monte Rosa Therapeutics, Inc. (GLUE) has filed 23 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 2 Form 8-K material event filings were reported by GLUE in the last 90 days. 16 Form 144 notices of proposed sale were filed for GLUE stock. InsiderAlpha tracks every GLUE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001826457 |
|---|
| Form 4 filings (90d) | 23 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 16 |
| Latest Form 4 filing | 2026-07-07 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Townson Sharon | Chief Scientific Officer | S — Open-market sale | 5.6K | $23.25 | $130K | SEC | |
| Townson Sharon | Chief Scientific Officer | S — Open-market sale | 400 | $24.13 | $10K | SEC | |
| Townson Sharon | Chief Scientific Officer | M — Option exercise | 6.0K | $6.14 | $37K | SEC | |
| Behbahani Ali | Insider | J — Other acquisition / disposition | 1.00M | $0.00 | — | SEC | |
| Behbahani Ali | Insider | J — Other acquisition / disposition | 15.0K | $0.00 | — | SEC | |
| Behbahani Ali | Insider | J — Other acquisition / disposition | 15.0K | $0.00 | — | SEC | |
| Janku Filip | Chief Medical Officer | M — Option exercise | 5.4K | $13.41 | $73K | SEC | |
| Janku Filip | Chief Medical Officer | S — Open-market sale | 5.4K | $24.50 | $132K | SEC | |
| Janku Filip | Chief Medical Officer | M — Option exercise | 6.0K | $7.56 | $45K | SEC | |
| Janku Filip | Chief Medical Officer | S — Open-market sale | 6.0K | $22.95 | $138K | SEC | |
| Manning Anthony M. | Insider | M — Option exercise | 10.0K | $4.16 | $42K | SEC | |
| Manning Anthony M. | Insider | S — Open-market sale | 10.0K | $23.11 | $231K | SEC | |
| Janku Filip | Chief Medical Officer | M — Option exercise | 30.0K | $7.56 | $227K | SEC | |
| Janku Filip | Chief Medical Officer | S — Open-market sale | 30.0K | $21.42 | $643K | SEC | |
| Champoux Jennifer | Chief Operating Officer | M — Option exercise | 2.2K | $3.98 | $9K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Monte Rosa Therapeutics, Inc. (GLUE). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Townson Sharon | 13 | $487K |
| Janku Filip | 12 | $1.54M |
| Champoux Jennifer | 12 | $204K |
| Manning Anthony M. | 7 | $494K |
| Behbahani Ali | 4 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in GLUE insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live GLUE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.